artoo
artoo makes any-to-any clinical dataset conversion lossless by construction.
A side-by-side editorial comparison of checkhelper and PowerTOST — release velocity, themes, recent moves, and the top alternatives to consider.
checkhelper grew from a check wrapper into a CRAN pre-submission auditor.
1.0.0 added a whole audit_* family — audit_downloads(), audit_description(), audit_dontrun() and audit_citation() — each parsing package source statically and returning a tibble of hits paired with a suggested fix. The package is now defending that position: 1.0.1 rc1 is a submission candidate answering a CRAN archival notice, after roxygen2 8.x moved DESCRIPTION's RoxygenNote field and broke a find_missing_tags() test fixture.
A bioequivalence sample-size workhorse whose news is which regulator it now covers
PowerTOST computes power and sample size for bioequivalence and its changelog reads as a record of regulatory divergence more than statistical development. Version 1.5-3 added the Gulf Co-operation Council as a regulator setting; 1.5-4 and 1.5-6 stripped 'FDA' out of the narrow-therapeutic-index function names once China's CDE began requiring the same evaluation. The most recent release, 1.5-7, is a single fix to how nvec() splits a total sample size across sequences.
1.0.0 added a whole audit_* family — audit_downloads(), audit_description(), audit_dontrun() and audit_citation() — each parsing package source statically and returning a tibble of hits paired with a suggested fix. The package is now defending that position: 1.0.1 rc1 is a submission candidate answering a CRAN archival notice, after roxygen2 8.x moved DESCRIPTION's RoxygenNote field and broke a find_missing_tags() test fixture.
The design commitment is static analysis — AST walks via getParseData(), line-by-line Rd reading, no eval() and no namespace loading — so the tool can report on a package it never runs. That commitment is what made the roxygen2 8.x break survivable: the audit pipeline itself was verified correct under 8.1.0 and only the test scaffolding had to go, now guarded by a dedicated regression test. fix_globals(write = TRUE) is being sanded down in parallel, no longer flattening per-function grouping comments or writing a degenerate empty globalVariables() shell.
The immediate move is the 1.0.1 submission itself, clearing the archival notice. Beyond that, each additional CRAN incoming-check rule remains a candidate for another audit_* function; the open question these notes still leave is whether the family ever gets a single combined entry point.
PowerTOST computes power and sample size for bioequivalence and its changelog reads as a record of regulatory divergence more than statistical development. Version 1.5-3 added the Gulf Co-operation Council as a regulator setting; 1.5-4 and 1.5-6 stripped 'FDA' out of the narrow-therapeutic-index function names once China's CDE began requiring the same evaluation. The most recent release, 1.5-7, is a single fix to how nvec() splits a total sample size across sequences.
The package is in long maintenance with a widening regulatory surface: the statistical methods are settled, and releases arrive when an agency publishes a framework that can be expressed as a settings variant of an existing method. Function naming has been deliberately decoupled from any single agency, with the deprecated FDA-suffixed aliases carried for years before removal. Cadence has slowed to roughly one release every eighteen months.
The next release is most likely another regulator setting or a small fix; on the deprecation notice already given, the power.NTIDFDA()-style aliases are the obvious removal candidate.
Other Infra & APIs products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either checkhelper or PowerTOST.
artoo makes any-to-any clinical dataset conversion lossless by construction.
tabular went from clinical tables to complete TFL output in under two months.
usmapdata ships its 2025 shapefiles on the year-indexed model it adopted in 0.4.0.
glcdp reaches 1.0.0 with a stable schema contract behind its data explorer.
prova adds expected-utility calculation on top of its Bayesian inference core.
Four years dormant, rstudio.prefs returns under a new maintainer.
See all checkhelper alternatives → · See all PowerTOST alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
They serve adjacent needs but don't currently overlap on shipped themes. checkhelper is currently shipping more aggressively (velocity 2.5 vs 0.0), with 0 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. checkhelper is currently shipping more aggressively (velocity 2.5 vs 0.0), with 0 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Infra & APIs products to evaluate alongside.
Top checkhelper alternatives in Infra & APIs are ranked by recent ship velocity. Browse the "checkhelper alternatives" section above for the current picks, or visit /alternatives/checkhelper for the full list with editorial commentary on each.
Top PowerTOST alternatives in Infra & APIs are ranked by recent ship velocity. Browse the "PowerTOST alternatives" section above for the current picks, or visit /alternatives/powertost for the full list with editorial commentary on each.